ELI LILLY AND COMPANY Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
ELI LILLY AND COMPANY (LLY) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.00 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2022-02-23
- ELI LILLY AND COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2020-09-30 was $0.00.
- ELI LILLY AND COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2020-06-30 was $0.00.
- ELI LILLY AND COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- ELI LILLY AND COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2019-12-31 was $0.00.
- ELI LILLY AND COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2021 was $0.00.
- ELI LILLY AND COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- ELI LILLY AND COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2019 was $3.95, a 5542.86% increase from fiscal 2018.
- ELI LILLY AND COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2018 was $0.07.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-23 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-23 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-10-28 | $0.00 10-Q · filed 2020-10-28 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-07-31 | $0.00 10-Q · filed 2020-07-31 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2020-02-19 | $3.95 10-K · filed 2022-02-23 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-10-28 | $3.92 10-Q · filed 2020-10-28 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-31 | $3.87 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $3.76 10-Q · filed 2020-05-01 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-19 | $0.07 10-K · filed 2021-02-17 | ||
| 2018-09-30 | $0.06 10-K · filed 2020-02-19 | $0.08 10-Q · filed 2019-10-25 | ||
| 2018-06-30 | -$0.03 10-K · filed 2020-02-19 | $0.02 10-Q · filed 2019-08-02 | ||
| 2018-03-31 | $0.05 10-K · filed 2020-02-19 | |||
| 2017-12-31 | -$0.10 8-K · filed 2019-10-24 | -$0.11 10-K · filed 2020-02-19 | ||
| 2017-09-30 | $0.01 8-K · filed 2019-10-24 | |||
| 2017-06-30 | $0.00 8-K · filed 2019-10-24 | |||
| 2017-03-31 | -$0.02 8-K · filed 2019-10-24 | |||
| 2016-12-31 | $0.02 8-K · filed 2019-10-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |